Search Results

You are looking at 1 - 1 of 1 items for :

  • Top-cited articles of 2023 x
  • Refine by access: All content x
Clear All
Justine Vanhevel Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium

Search for other papers by Justine Vanhevel in
Google Scholar
PubMed
Close
,
Lieve Verlinden Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium

Search for other papers by Lieve Verlinden in
Google Scholar
PubMed
Close
,
Stefanie Doms Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium

Search for other papers by Stefanie Doms in
Google Scholar
PubMed
Close
,
Hans Wildiers UZ Leuven, General Medical Oncology and Multidisciplinary Breast Center, Leuven, Belgium

Search for other papers by Hans Wildiers in
Google Scholar
PubMed
Close
, and
Annemieke Verstuyf Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium

Search for other papers by Annemieke Verstuyf in
Google Scholar
PubMed
Close

was previously shown that 1,25(OH) 2 D 3 treatment decreased ERα protein and mRNA levels in MCF7 cells ( Swami et al. 2000 ) and aromatase expression in MCF7 tumour xenografts and surrounding adipose tissue ( Krishnan et al. 2010 ), the

Free access